Evidence map›Paper›PMID 35550003›Full record

ArticleTrials2022

Success and failure factors of patient recruitment for industry-sponsored clinical trials and the role of the electronic health records-a qualitative interview study in the Nordic countries.

Niina Laaksonen, Mia Bengtström, Anna Axelin, Juuso Blomster, Mika Scheinin, Risto Huupponen

Abstract read
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Clinical research in private hospitals: a perspective.Journal of translational medicine · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Phase 1 Clinical Trials: Challenges and Opportunities in Latin America.Journal of immunotherapy and precision oncology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Niina LaaksonenInstitute of Biomedicine, University of Turku, Turku, Finland. niinie@utu.fi.ORCID http://orcid.org/0000-0001-6764-5397
Mia BengtströmPharma Industry Finland, Helsinki, Finland.
Anna AxelinDepartment of Nursing Science, University of Turku, Turku, Finland.
Juuso BlomsterDepartment of Cardiology, University of Turku and Turku University Hospital, Turku, Finland.
Mika ScheininInstitute of Biomedicine, University of Turku, Turku, Finland.
Risto HuupponenInstitute of Biomedicine, University of Turku, Turku, Finland.

Funding

Finnish Pharmaceutical Industry Research Foundation NA
6 · The paper itself

Abstract

backgroundPatient recruitment for clinical trials is challenging-only approximately one third of all trials recruit their participants as planned. The pharmaceutical industry's views on recruitment success have not been comprehensively investigated, although the industry globally conducts almost one third of all clinical drug trials. This study explored patient recruitment success and failure factors and the role of electronic health records (EHR) in the recruitment of trial participants in the Nordic countries.

methodsA descriptive qualitative interview study was conducted with 21 representatives of the pharmaceutical industry or contract research organizations operating in Finland, Sweden, Denmark, and Norway. The interviews covered 34 clinical pre-market drug trials. Qualitative data were analyzed using inductive content analysis.

resultsFour main categories were derived to represent both success and failure factors, whereas a fifth category represented only failure factors: (1) sponsor-related (protocol and trial preparation and feasibility evaluations), (2) site/investigator-related (access to patients, motivation, commitment and resources), (3) patient-related recruitment factors (medical need, patients' role in their care and attitudes towards trials), (4) Sponsor-sites-patients collaboration factors, and (5) start-up related factors. EHR was the most important source of recruitment, utilized in 29 out of 34 trials discussed. Revision of the legislation regulating the secondary use of EHR was highlighted as the most effective measure to facilitate the use of EHR in recruitment of trial participants.

conclusionsThe industry representatives recognized quite well their own role in contributing to the success or failure of the recruitment: to facilitate recruitment of trial participants, many obstacles can be avoided with better trial preparation and proper feasibility evaluations. As access to patients represents one of the key success or failure factors of recruitment, and as the EHR is regarded the main source of searching for and finding patients, the development of EHR utilization appears to represent a powerful tool to improve patient recruitment.

Indexed as

Clinical Trials as TopicElectronic Health RecordsPatient SelectionHumansQualitative ResearchResearch PersonnelScandinavian and Nordic CountriesClinical trialsElectronic health recordsFailureInterviewNordic countriesPatient recruitmentQualitativeSuccess factors

Identifiers

PMID35550003
PMCPMC9097356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.